Original StudiesImpact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central ItalyBONANNI, PAOLO MD; COLOMBAI, RENATO MD; GASPARINI, ROBERTO MD; LO NOSTRO, ANTONELLA DBIOL; TISCIONE, EMILIA DBIOL; TOMEI, ALESSIA MD; MONTOMOLI, EMANUELE DBIOL; COMODO, NICOLA DBIOLAuthor Information From the Public Health and Epidemiology Department, University of Florence, Florence (PB, ALN, ET, AT, NC); Health Management Service, Hospital S. Chiara, Pisa (RC); and Institute of Hygiene, University of Siena, Sienna (RG, EM), Italy. Accepted for publication April 15, 1999. Address for reprints: Paolo Bonanni, M.D., Public Health and Epidemiology Department, University of Florence, Viale G. B. Morgagni, 48, 50134 Florence, Italy. Fax 39-055-4222541; E-mail firstname.lastname@example.org. The Pediatric Infectious Disease Journal: August 1999 - Volume 18 - Issue 8 - p 677-682 Buy Abstract Background. In Italy routine infant and adolescent immunization against hepatitis B was introduced in 1991. Objective. Evaluation of (1) coverage with three doses of hepatitis B vaccine in infants and adolescents; (2) seroconversion to anti-hepatitis B surface antigen antibody (anti-HBs) in adolescents receiving three doses of vaccine; (3) concordance of coverage rates in infants with prevalence of neutralizing antibodies in sera from anonymous children; (4) trend of notified cases of acute hepatitis B. Methods. A sample of infants and adolescents living in Tuscany was studied during 6 years (1992 through 1997) by matching birth records and immunization certificates. Sera from 139 adolescents who completed the vaccination course and from 159 anonymous children belonging to immunized cohorts (1 to 5 years) were tested with a quantitative anti-HBs assay. Incidence of acute hepatitis B by age was calculated from regional statistics on notified infectious diseases between 1992 and 1996. Results. Overall 10 606/11 164 (95%) infants and 10 599/11 100 (95%) adolescents received 3 doses of vaccine. Seroconversion to anti-HBs was detected in 98% of adolescent vaccinees. Anti-HBs titers ≥10 IU/l were detected in 87% of children. A 49% decline of acute hepatitis B cases was registered between 1992 and 1996 in 15- to 24-year-olds living in Tuscany. No case occurred in vaccinated adolescents. Conclusions. Coverage against hepatitis B is excellent in cohorts subject to mandatory immunization. If efforts to vaccinate are maintained at these levels, elimination of hepatitis B virus transmission could occur within few decades in Italy. © 1999 Lippincott Williams & Wilkins, Inc.